A federal judge today in Washington, D.C. scrutinized arguments from both manufacturers and the government in a closely watched hearing [...] …
Category: Federal
A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...] …
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...] …
Two influential players in the 340B world have recently taken on key positions at retail pharmacy giant Walgreens, one of [...] …
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...] …
News Alert
Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...] …
The leader of a key U.S. Senate Committee tasked with overseeing the 340B program called Thursday for Congress to improve [...] …
While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...] …
The drug industry is bracing for the Trump administration’s planned tariffs on pharmaceutical products and ingredients, warning of supply chain [...] …
The leaders of four health systems recently met with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and [...] …